Halozyme Therapeutics, Inc. (HALO Quick QuoteHALO - Free Report) was a big mover last session, as the company saw its shares rise above 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $9.88 to $12.61 in the past one-month time frame.

In the last 30 days, the company has seen no estimate revision and the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.       

Halozyme Therapeutics currently carries a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Halozyme Therapeutics, Inc. Price

 

Halozyme Therapeutics, Inc. Price | Halozyme Therapeutics, Inc. Quote

A better-ranked Medical-Biomedical and Genetics stock is Enzo Biochem, Inc. (ENZ Quick QuoteENZ - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is HALO going up? Or down? Predict to see what others think: Up or Down

Zacks' Top 10 Stocks for 2017

In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017? Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>